CHG-2023-0286
Manufacturing Process Change for Retinavab. Manufacturing Process Change for Retinavab — critical change. Impacts 4 markets and 1 variations.
Change Number
CHG-2023-0286
Type
Manufacturing Process Change
Product
Status
In Progress
Owner
Carlos Mendez
Initiated
2022-11-03
Description
Manufacturing Process Change for Retinavab — critical change
Impacted Markets (4)
KR — South KoreaTR — TurkeyZA — South AfricaBE — Belgium
Impacted Modules
3.2.S5.3.52.3.P3.2.P.3
Linked Variations (0)
| Variation # | Type | Application | Status | Submitted | Approved |
|---|